Beyond being required by law, data transparency in clinical trials is also an ethical and business critical aspect of drug development. Data Transparency is important to reduce avoidable burden on and/or risk to trial subjects due to the avoidance of unwarranted trial repetition, enable data-driven decisions by healthcare professionals, regulators, price selection, and pharmaceutical companies, and finally to ensure unbiased reporting of clinical trials. Throughout this Conference, we will tackle data transparency from different angles with experts from the field.
3 Key objectives for this Conference:
Session 1: Regulatory Aspects & Updates
Session 2: Regulatory Aspects & Updates
Session 3: How are the rules lived
Session 4: Pro-active Approach
Session 5: Anonymisation
Session 6: Workshop around anonymisations
Session 7: The future of Data Transparency - Panel discussion
A detailed programme can be found here.
More information & registration via: http://www.eccrt.com/events/eccrt-data-transparency-conference